Medical Services International to Make Its VScan Rapid Test Kit for the Detection of Tuberculosis Available to the Passengers of
June 11 2007 - 12:58AM
PR Newswire (US)
NEW YORK, June 11 /PRNewswire-FirstCall/ -- Medical Services
International Inc. (Pink Sheets: MSITF) wishes to announce that it
will make available, at no cost, every 3 months for the next two
years its VScan rapid test kit for Tuberculosis (TB) to all
passengers and crew that can verify that they were on the Czech
Airlines flight from Prague to Montreal where the individual had
Tuberculosis (TB). The VScan TB rapid test kit is a screening test
that will tell the individual using it if they have gone from
inactive to active TB status. The VScan TB test kit is faster and
easier than conventional testing. The VScan TB rapid test kit only
detects "live" TB and does NOT give false positives. It is the only
kit that does not give false positives. There is no test available
that is more accurate. It will detect a change in status from
inactive to active (live) status faster than conventional testing.
Current testing available other than the VScan TB test gives false
positives 30% of the time. Using the VScan rapid test kit does not
mean that individuals should ignore the advice of their doctor. As
it will take a significant amount of time before the status of the
individuals can be determined, the Company feels that having the
availability of its VScan TB test kit will reduce some of the
anxiety associated with this situation. For further information
please call (780) 430 6363. About VScan The VScan rapid test kit is
a single use, disposable, accurate, cost effective, easy to use,
test for the screening of HIV 1&2, Tuberculosis (TB), Hepatitis
B&C, Dengue Fever, West Nile, Syphilis, Malaria and Prostate
Cancer. The kits cannot be sold in Canada. Medical Services
International Inc. trades in the United States on the NQB Pink
Sheets under the symbol "MSITF". For further information, please
contact Robert Talbot at (780) 430 6363 or
http://www.medicalservicesintl.com/ or
http://www.minerva-biotech.com/. NOTE: Certain statements in this
press release are "forward-looking statements" within the meaning
of the Private Securities Act of 1995. Such statements involve
known and unknown risks, uncertainties and other factors that may
cause results to differ materially. Such risks, uncertainties and
other factors include but are not limited to new economic
conditions, risk in product development, market acceptance of new
products and continuing product demand, level of competition and
other factors described in Company reports and other filings with
regulatory bodies. DATASOURCE: Medical Services International Inc.
CONTACT: Robert Talbot of Medical Services International Inc.,
+1-780-430-6363 Web site: http://www.medicalservicesintl.com/
http://www.minerva-biotech.com/
Copyright